Announcements Trials
Browse Landscape

Phase

Phase 2 59Phase 1 21Phase NA 15Phase 3 11Phase 1/2 10Phase EARLY_PHASE1 3Phase 4 2Phase 2/3 2

Status

Completed 27Recruiting 10Unknown 8Not yet recruiting 3Terminated 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 29Genitourinary 23Thoracic 20Breast 19Other hematologic neoplasm 16Lymphoid 14Dermatologic 10Gynecologic 8Classical hematology 8Head & Neck 6Myeloid 5CNS 4Tumor-Agnostic 3Sarcoma 3Other 3Plasma cell 2Endocrine 2Other solid neoplasm 1Other neoplasm 1NET 1

Conditions

Serotonin Syndrome 1Pituitary Neoplasms 1Neuroendocrine Tumors 1Gigantism 1Acromegaly 1

Interventions

lanreotide 1Octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Endocrine × Clear all
NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated
4 enrolled 5 charts
Endocrine

Acromegaly, Gigantism, Pituitary Neoplasms

NCT04140409 2019-10-25

SCIROCCO

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 4 Terminated
10 enrolled
EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡